At first, we investigated FOXM1 activity because FOXM1 was identified as an important substrate of MELK in glioma stem cells [23] and its activity was attenuated by OTS167 in acute myeloid leukemia cells [8]. This evidence concerns the gene MELK and central nervous system cancer.